An interventional study of ANS training in Turner Syndrome, sponsored by Stanford University. Withdrawn at 1 site in United States. Open to female participants aged 6 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-09.
Sponsored by Stanford University · Not applicable, Interventional, and Treatment
This study evaluates approximate number sense (ANS) in children, adolescents, and adult women with Turner syndrome compared to age-matched healthy peers. One primary aim of this project is to assess the effectiveness of an online ANS training tool in enhancing complex mathematics ability. Participants will undergo weekly training sessions in their own home. Half of the participants will complete 2 training sessions a week for 8 weeks, and the second half will complete 1 training session for 8 weeks.
119 studies on the registry are indexed under Turner Syndrome; 33 are open to participants now.
Browse Turner Syndrome studies →Stanford University is the lead sponsor of 2,161 studies on the registry; 428 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: ANS training
In-home computer-based ANS training
Single and multiple-operand addition and subtraction accuracy
Task accuracy calculated as the percentage of trials answered correctly.
Time frame: 8 weeks
Single and multiple-operand addition and subtraction response time
Average amount of time, in seconds, required to answer each question on the task.
Time frame: 8 weeks
Plan to share: Undecided — De-identified individual participant data for the primary outcome measures may be made available upon reasonable request.
No publications or documents are linked to this record.
This study is withdrawn, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.